Tubulin-β-III overexpression by uterine serous carcinomas is a marker for poor overall survival after platinum/taxane chemotherapy and sensitivity to epothilones

Cancer statistics, 2012

(2012) Rebecca Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Gender Influences the Class III and V  -Tubulin Ability to Predict Poor Outcome in Colorectal Cancer

(2012) M. Mariani et al.   CLINICAL CANCER RESEARCH

Differential in vitro sensitivity to patupilone versus paclitaxel in uterine and ovarian carcinosarcoma cell lines is linked to tubulin-beta-III expression

(2011) Luisa Carrara et al.   GYNECOLOGIC ONCOLOGY

Expression of ERCC1, p53, and Class III β-Tubulin Do Not Reveal Chemoresistance in Endometrial Cancer

(2011) Ingrid Vandenput et al.   INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER

Overcoming tumor multidrug resistance using drugs able to evade P-glycoprotein or to exploit its expression

(2011) Stefania Nobili et al.   MEDICINAL RESEARCH REVIEWS

Specific β-Tubulin Isotypes Can Functionally Enhance or Diminish Epothilone B Sensitivity in Non-Small Cell Lung Cancer Cells

(2011) Pei Pei Gan et al.   PLoS One

Differential sensitivity to platinum-based chemotherapy in primary uterine serous papillary carcinoma cell lines with high vs low HER-2/neu expression in vitro

(2010) Sarah N. Cross et al.   AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY

Autocrine production of interleukin-6 confers cisplatin and paclitaxel resistance in ovarian cancer cells

(2010) Yue Wang et al.   CANCER LETTERS

Treatment options for advanced endometrial carcinoma

(2010) Don S. Dizon   GYNECOLOGIC ONCOLOGY

Limitations of MTT and MTS-Based Assays for Measurement of Antiproliferative Activity of Green Tea Polyphenols

(2010) Piwen Wang et al.   PLoS One

Ovarian Low-grade and High-grade Serous Carcinoma

(2009) Russell Vang et al.   ADVANCES IN ANATOMIC PATHOLOGY

In vitro activity of pertuzumab in combination with trastuzumab in uterine serous papillary adenocarcinoma

(2009) K El-Sahwi et al.   BRITISH JOURNAL OF CANCER

Phase II Trial of Ixabepilone As Second-Line Treatment in Advanced Endometrial Cancer: Gynecologic Oncology Group Trial 129-P

(2009) Don S. Dizon et al.   JOURNAL OF CLINICAL ONCOLOGY

The role of βIII tubulin in predicting chemoresistance in non-small cell lung cancer

(2009) Pascal Sève et al.   LUNG CANCER

Intercepting pelvic cancer in the distal fallopian tube: Theories and realities

(2009) Christopher P. Crum   Molecular Oncology

Pharmacokinetic profile of the microtubule stabilizer patupilone in tumor-bearing rodents and comparison of anti-cancer activity with other MTS in vitro and in vivo

(2008) Terence O’Reilly et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Molecular Mechanisms of Patupilone Resistance

(2008) S. Mozzetti et al.   CANCER RESEARCH